CLINICAL_TRIALS ClinicalTrials.gov record update

Immune Response Surveillance and Potential Booster Vaccines for Patients Who Have Received HER2-pulsed DC1 Vaccine

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03630809
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:41.725612+00:00
Published At: 2022-04-25T00:00:00+00:00
Record Updated At: 2022-04-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Breast Cancer", "HER2-positive Breast Cancer", "HER-2 Gene Amplification", "HER2 Positive Breast Carcinoma", "HER-2 Protein Overexpression", "Breast Cancer, Male", "Breast Cancer Female"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-04-25"
protocolSection.identificationModule.nctId: "NCT03630809"
protocolSection.identificationModule.officialTitle: "Immune Response Surveillance and Potential Booster Vaccines for Patients Who Have Received HER2-pulsed DC1 Vaccine"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.